Related Experiment Video
Updated: Jun 22, 2026

Three-dimensional Confocal Analysis of Microglia/macrophage Markers of Polarization in Experimental Brain Injury
Published on: September 4, 2013
C5aR1+ microglia exacerbate neuroinflammation and cerebral edema in acute brain injury
Jinpeng Zhou1, Shuoyao Ma1, Dayun Feng1
1Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China.
Abstract:
Microglia rapidly respond to acute brain injury and contribute to neuroinflammation that drives cerebral edema, a major cause of mortality and disability in stroke and traumatic brain injury (TBI). However, microglial heterogeneity complicates precise therapeutic targeting because specific disease-associated subtypes remain poorly characterized. Here, we define a previously unrecognized C5a receptor 1 (C5aR1)-expressing microglial subtype enriched in human cerebral edema tissue from decompressive surgery for TBI and intracerebral hemorrhage (ICH). In preclinical models, C5aR1+ microglia engage locally and peripherally derive C5a to amplify neuroinflammation, drive neurotoxic astrocyte polarization, and recruit neutrophils, leading to cerebral edema. Genetic ablation of microglial C5ar1 or its pharmacological inhibition with an Food and Drug Administration (FDA)-approved antagonist attenuates cerebral edema in both TBI and ICH. These findings delineate the role of C5aR1+ microglia in neuroinflammatory cascades and cerebral edema following acute brain injury, indicating C5aR1 as a potential therapeutic target.
Insights
A novel microglial subtype expressing C5a receptor 1 (C5aR1) drives brain swelling after injury. Targeting C5aR1 reduces cerebral edema in traumatic brain injury and intracerebral hemorrhage models.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Microglia are key immune cells in the brain, responding rapidly to injury.
- Neuroinflammation and cerebral edema are critical factors in stroke and traumatic brain injury (TBI) outcomes.
- Microglial heterogeneity presents challenges for targeted therapies.
Purpose of the Study:
- To identify and characterize novel microglial subtypes involved in acute brain injury.
- To investigate the role of C5a receptor 1 (C5aR1) in microglial-mediated neuroinflammation and cerebral edema.
- To evaluate C5aR1 as a potential therapeutic target for acute brain injury.
Main Methods:
- Analysis of human cerebral edema tissue from TBI and intracerebral hemorrhage (ICH) patients.
- Preclinical models of TBI and ICH to study microglial responses.
- Genetic ablation of the C5ar1 gene in microglia.
- Pharmacological inhibition of C5aR1 using an FDA-approved antagonist.
Main Results:
- A distinct microglial subtype expressing C5aR1 was identified in human cerebral edema.
- C5aR1+ microglia amplify neuroinflammation, promote neurotoxic astrocyte polarization, and recruit neutrophils in preclinical models.
- Genetic or pharmacological inhibition of C5aR1 significantly reduced cerebral edema in TBI and ICH models.
- C5aR1+ microglia were found to engage with both local and peripherally derived C5a.
Conclusions:
- C5aR1+ microglia represent a critical driver of cerebral edema following acute brain injury.
- Targeting C5aR1 offers a promising therapeutic strategy to mitigate brain swelling and improve outcomes in TBI and ICH.
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Cerebral Edema l: Introduction
Cerebral Edema ll: Pathophysiology
Cytotoxic Edema: Pathophysiology

